Additional file 2 of Convergent network effects along the axis of gene expression during prostate cancer progression

Additional file 2: Table S1. Clinicopathological, immunological and other molecular information of the 39 PCa patients. (a) Overall clinicopathological characteristics. (b) Detailed information for each patient. Pat: numeric patient ID; Pat_id: patient ID grouped by the overall grade. L: low grade; M: intermediate grade; H: high grade; Overall_Gleason_GrGp: overall ISUP grade group; pT: tumor stage; pN: nodal status; R: surgical margin status; Age_at_OP: age at operation; PSA_at_Diag: blood PSA level at diagnosis; Time (months): RFS time. A value of 0 corresponds to patients excluded for the reasons explained in the ‘Methods’ section (see ‘Patients and samples’); Status: status indicator. 1 means recurrence; DX name: tissue region name; ImageName: name of the scanned images; index_tumor_id: patient ID of TA1 (or TA); TA1_GrGp: grade group for TA1; T_GrGp: grade group for TA2.

附加文件2：表S1。39例前列腺癌（PCa, Prostate Cancer）患者的临床病理、免疫及其他分子信息。(a) 整体临床病理特征；(b) 单例患者详细信息。Pat：数字型患者编号；Pat_id：按总体分级分组的患者编号。L：低级别；M：中级别；H：高级别；Overall_Gleason_GrGp：总体ISUP（International Society of Urological Pathology）分级组；pT：肿瘤分期；pN：淋巴结状态；R：手术切缘状态；Age_at_OP：手术时年龄；PSA_at_Diag：诊断时的血液前列腺特异性抗原（PSA, Prostate-Specific Antigen）水平；Time（月）：无复发生存（RFS, Recurrence-Free Survival）时间。取值为0的条目对应于‘方法’部分（参见‘患者与样本’小节）中说明的原因被排除的患者；Status：状态指示符，1代表肿瘤复发；DX name：组织区域名称；ImageName：扫描图像文件名；index_tumor_id：TA1（或TA）对应的患者编号；TA1_GrGp：TA1的分级组；T_GrGp：TA2的分级组。